Clark Eliana insider trades
Clark Eliana has filed 13 Form 4s with the SEC that we hold, all for Intellia Therapeutics, Inc. (NTLA), as EVP, Chief Technical Officer. Across all of them we count 0 purchases worth $0 and 15 sales worth $690.4K reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($96.0K). The largest single trade was a sale of 5,000 shares of Intellia Therapeutics, Inc. worth $225.0K, dated 2023-06-20. The first filing on our record is dated 2022-03-07 and the latest 2026-03-03.
Intellia Therapeutics, Inc. (NTLA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-07-01 | S, sale reported on Form 4 | 105 | $5.4K | 2023-01-06 |
| 2023-01-03 | S, sale reported on Form 4 | 231 | $8.0K | 2023-01-06 |
| 2023-01-04 | S, sale reported on Form 4 | 1,692 | $63.0K | 2023-01-06 |
| 2023-06-20 | S, sale reported on Form 4 | 5,000 | $225.0K | 2023-06-22 |
| 2023-07-03 | S, sale reported on Form 4 | 360 | $14.6K | 2023-07-06 |
| 2024-01-03 | S, sale reported on Form 4 | 307 | $9.2K | 2024-01-05 |
| 2024-01-03 | S, sale reported on Form 4 | 4,301 | $126.7K | 2024-01-05 |
| 2024-03-04 | S, sale reported on Form 4 | 605 | $20.0K | 2024-03-05 |
| 2024-07-01 | S, sale reported on Form 4 | 405 | $9.3K | 2024-07-03 |
| 2025-01-02 | S, sale reported on Form 4 | 556 | $6.7K | 2025-01-06 |
| 2025-01-03 | S, sale reported on Form 4 | 7,422 | $90.4K | 2025-01-06 |
| 2025-03-04 | S, sale reported on Form 4 | 679 | $6.1K | 2025-03-04 |
| 2025-07-01 | S, sale reported on Form 4 | 1,022 | $10.0K | 2025-07-03 |
| 2026-01-05 | S, sale reported on Form 4 | 9,515 | $87.6K | 2026-01-07 |
| 2026-03-02 | S, sale reported on Form 4 | 607 | $8.4K | 2026-03-03 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1914448) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms